by Suzanne Burdick, Ph.D., Childrens Health Defense:

The World Health Organization (WHO) today approved the first mpox vaccine for use in adults — and also said it can be used for babies, children, teens and pregnant women if they are in “outbreak settings where the benefits of vaccination outweigh the potential risks.”

WHO’s approval of Bavarian Nordic’s vaccine will help governments and international agencies such as the Gavi, the Vaccine Alliance, and UNICEF, buy it, MedicalXpress reported.